Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

Excluding intrathecal inflammation using the kFLC index in CSF

In this presentation, Prof. Süße explains the concept of excluding intrathecal inflammation by measuring kappa free light chain (kFLC) in CSF and serum and introduces a prospective multicenter validation study of this new laboratory workflow integrating the free light chains kappa quotient in CSF analysis. The measurement of κFLC in cerebrospinal fluid (CSF) and serum is a newer but already well-established and sensitive biomarker to detect intrathecal immunoglobulin synthesis. Recently it has been proposed to use κFLC in CSF as a primary exclusion marker for intrathecal inflammation, which would significantly change the workflow for neurological patients.

2023-11-11
Marie Süße, Greifswald University Medical Center

Dr. Marie Süße
Senior Physician for Neurology
Neurology Clinic and Polyclinic
Greifswald University Medical Center
Greifswald, Germany